Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q5002519> ?p ?o }
Showing triples 1 to 25 of
25
with 100 triples per page.
- Q5002519 subject Q15213351.
- Q5002519 subject Q7215860.
- Q5002519 subject Q8805811.
- Q5002519 abstract "Buthionine sulfoximine (BSO) is a sulfoximine which reduces levels of glutathione and is being investigated as an adjunct with chemotherapy in the treatment of cancer. The compound inhibits gamma-glutamylcysteine synthetase, the enzyme required in the first step of glutathione synthesis. Buthionine sulfoximine may also be used to increase the sensitivity of parasites to oxidative antiparasitic drugs.".
- Q5002519 iupacName "2-amino-4-(butylsulfonimidoyl)butanoic acid".
- Q5002519 thumbnail Buthionine_sulfoximine.svg?width=300.
- Q5002519 wikiPageWikiLink Q116907.
- Q5002519 wikiPageWikiLink Q15213351.
- Q5002519 wikiPageWikiLink Q186517.
- Q5002519 wikiPageWikiLink Q281166.
- Q5002519 wikiPageWikiLink Q5572430.
- Q5002519 wikiPageWikiLink Q581102.
- Q5002519 wikiPageWikiLink Q7215860.
- Q5002519 wikiPageWikiLink Q8047.
- Q5002519 wikiPageWikiLink Q8805811.
- Q5002519 wikiPageWikiLink Q974135.
- Q5002519 iupacname "2".
- Q5002519 type ChemicalCompound.
- Q5002519 type ChemicalSubstance.
- Q5002519 type ChemicalObject.
- Q5002519 type Thing.
- Q5002519 type Q11173.
- Q5002519 comment "Buthionine sulfoximine (BSO) is a sulfoximine which reduces levels of glutathione and is being investigated as an adjunct with chemotherapy in the treatment of cancer. The compound inhibits gamma-glutamylcysteine synthetase, the enzyme required in the first step of glutathione synthesis. Buthionine sulfoximine may also be used to increase the sensitivity of parasites to oxidative antiparasitic drugs.".
- Q5002519 label "Buthionine sulfoximine".
- Q5002519 depiction Buthionine_sulfoximine.svg.